Welcome to our X channel, your go-to platform for learning about the stock market, fundamental investing, finance,business model analysis and I m qualified CA
📊 FY26 Snapshot
Revenue: ₹827 Cr
PAT: ₹187 Cr
Strong balance sheet, expanding capacities, growing global presence and a focused specialty API strategy position Supriya Lifescience well for the next phase of growth.
#PharmaStocks#SupriyaLifescience#LongTermInvesting
Key growth drivers for #UnimechAerospace:
✈️ Aerospace manufacturing
🛡️ Defence opportunities
🌍 Export expansion
⚙️ High-precision engineering
Management continues to focus on scaling capabilities and strengthening its order pipeline.
#Defence#Aerospace#IndiaGrowthStory
#TechnoElectric Key Monitorables 🔍
➡️ Order book growth
➡️ Margin sustainability
➡️ Renewable energy opportunities
➡️ Data center expansion plans
Market participants will closely track execution and future order inflows. 📈
⚠️ Disclaimer: No buy or sell recommendation.
#TechnoElectric Operational Highlights 👀
✅ Healthy growth in transmission & infrastructure projects
✅ Strong order execution during FY26
✅ Data center & power infra opportunities remain key growth drivers
✅ Revenue crossed ₹34,000 Mn in FY26
#PowerSector#IndianStocks